dc.contributor.author |
Zhu, Shenshan |
|
dc.contributor.author |
Shi, Qiaoyun |
|
dc.contributor.author |
Lu, Jian |
|
dc.date.accessioned |
2022-11-16T07:54:15Z |
|
dc.date.available |
2022-11-16T07:54:15Z |
|
dc.date.issued |
2018-05-20 |
|
dc.identifier.citation |
Zhu, S., Shi, Q., & Lu, J. (2018). Curative effect of oral ulcer powder on the treatment of recurrent aphthous ulcer. Pak J Pharm Sci, 31(3), 1175-8. |
en_US |
dc.identifier.issn |
1011-601X |
|
dc.identifier.uri |
http://142.54.178.187:9060/xmlui/handle/123456789/14022 |
|
dc.description.abstract |
Recurrent aphthous ulcer (RAU) is a common and frequently occurring disease in the Department of Stomatology. The clinical manifestations are localized ulcer of oral mucosa, and the ulcer mask is self limiting and easy to recur. In this paper, by adopting the randomized study method, the author study the effect of oral ulcer powder combined with traditional Chinese drugs on patients with recurrent aphthous ulcer, and analyze its effect on inflammatory factor. Kangfuxin liquid combined with oral ulcer powder helps reduce recurrent aphthous ulcer patients the levels of inflammatory factors, improve the symptoms of pain. The recurrence rate of the patients in the observation group for 6 months was 12.8%, which was significantly lower than that of the control group (31.42%). The difference was statistically significant (P<0.05). At the same time, the average TNF- a, IL-1 and IL-6 water in the observation group were significantly lower than that of the control group, proving that the treatment regimen could reduce the inflammatory response. |
en_US |
dc.language.iso |
en |
en_US |
dc.publisher |
Karachi:Pakistan Journal of Pharmaceutical Sciences, university of Karachi. |
en_US |
dc.subject |
Inflammatory factors |
en_US |
dc.subject |
ulcer dispersal |
en_US |
dc.subject |
recurrent aphthous ulcer |
en_US |
dc.subject |
drug effect. |
en_US |
dc.title |
Curative effect of oral ulcer powder on the treatment of recurrent aphthous ulcer |
en_US |
dc.type |
Article |
en_US |